Ledger.Open graph →
SEC Form D · filed October 3, 2025

Enveric Biosciences, Inc

Offering
Sold
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

George W. Kegler · Cambridge, MADirectorMichael D. Webb · Cambridge, MADirectorSheila W. Dewitt · Cambridge, MADirectorJoseph E. Tucker · Cambridge, MAExec · DirectorMarcus W. Schabacker · Cambridge, MADirectorFrank W. Pasqualone · Cambridge, MADirectorKevin M. Coveney · Cambridge, MAExecFrank W. Pasqualone · Cambridge, MADirectorKevin M. Coveney · Cambridge, MAExecSheila W. Dewitt · Cambridge, MADirectorMichael D. Webb · Cambridge, MADirectorGeorge W. Kegler · Cambridge, MADirectorMarcus W. Schabacker · Cambridge, MADirectorJoseph E. Tucker · Cambridge, MAExec · DirectorSamuel M. Cummings · Grand Rapids, MIDirectorDaniel G. Devos · Grand Rapids, MIDirectorMadding King, Iii · Birmingham, ALExecJimmie H. Harvey, Jr · Birmingham, ALDirectorJames E. Cantrell, Jr · Birmingham, ALDirectorAndrew P. Aromando · Birmingham, ALDirectorJerry Brodie · Portland, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗